<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Klauser A</submitter><funding>Austrian Science Fund FWF</funding><funding>Swiss National Science Foundation</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><pagination>107048</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8717865</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>331</volume><pubmed_abstract>Low sensitivity MR techniques such as magnetic resonance spectroscopic imaging (MRSI) greatly benefit from the gain in signal-to-noise provided by ultra-high field MR. High-resolution and whole-slab brain MRSI remains however very challenging due to lengthy acquisition, low signal, lipid contamination and field inhomogeneity. In this study, we propose an acquisition-reconstruction scheme that combines &lt;sup>1&lt;/sup>H free-induction-decay (FID)-MRSI sequence, short TR acquisition, compressed sensing acceleration and low-rank modeling with total-generalized-variation constraint to achieve metabolite imaging in two and three dimensions at 7 Tesla. The resulting images and volumes reveal highly detailed distributions that are specific to each metabolite and follow the underlying brain anatomy. The MRSI method was validated in a high-resolution phantom containing fine metabolite structures, and in five healthy volunteers. This new application of compressed sensing acceleration paves the way for high-resolution MRSI in clinical setting with acquisition times of 5 min for 2D MRSI at 2.5 mm and of 20 min for 3D MRSI at 3.3 mm isotropic.</pubmed_abstract><journal>Journal of magnetic resonance (San Diego, Calif. : 1997)</journal><pubmed_title>Achieving high-resolution &lt;sup>1&lt;/sup>H-MRSI of the human brain with compressed-sensing and low-rank reconstruction at 7 Tesla.</pubmed_title><pmcid>PMC8717865</pmcid><funding_grant_id>R01 CA255479</funding_grant_id><funding_grant_id>J 4124</funding_grant_id><funding_grant_id>R01 CA211080</funding_grant_id><funding_grant_id>IZSEZ0_188859</funding_grant_id><funding_grant_id>188859</funding_grant_id><funding_grant_id>1R01CA211080</funding_grant_id><pubmed_authors>Strasser B</pubmed_authors><pubmed_authors>Thapa B</pubmed_authors><pubmed_authors>Lazeyras F</pubmed_authors><pubmed_authors>Klauser A</pubmed_authors><pubmed_authors>Andronesi O</pubmed_authors></additional><is_claimable>false</is_claimable><name>Achieving high-resolution &lt;sup>1&lt;/sup>H-MRSI of the human brain with compressed-sensing and low-rank reconstruction at 7 Tesla.</name><description>Low sensitivity MR techniques such as magnetic resonance spectroscopic imaging (MRSI) greatly benefit from the gain in signal-to-noise provided by ultra-high field MR. High-resolution and whole-slab brain MRSI remains however very challenging due to lengthy acquisition, low signal, lipid contamination and field inhomogeneity. In this study, we propose an acquisition-reconstruction scheme that combines &lt;sup>1&lt;/sup>H free-induction-decay (FID)-MRSI sequence, short TR acquisition, compressed sensing acceleration and low-rank modeling with total-generalized-variation constraint to achieve metabolite imaging in two and three dimensions at 7 Tesla. The resulting images and volumes reveal highly detailed distributions that are specific to each metabolite and follow the underlying brain anatomy. The MRSI method was validated in a high-resolution phantom containing fine metabolite structures, and in five healthy volunteers. This new application of compressed sensing acceleration paves the way for high-resolution MRSI in clinical setting with acquisition times of 5 min for 2D MRSI at 2.5 mm and of 20 min for 3D MRSI at 3.3 mm isotropic.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-04T12:04:30.264Z</modification><creation>2025-04-04T12:04:30.264Z</creation></dates><accession>S-EPMC8717865</accession><cross_references><pubmed>34438355</pubmed><doi>10.1016/j.jmr.2021.107048</doi></cross_references></HashMap>